Skip to content

New Approach for Ovarian PRP Injection for Poor Responders

New Approach for Ovarian PRP Injection for Poor Responders ; Aiming At the Highest Response Rate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06663930
Enrollment
21
Registered
2024-10-29
Start date
2024-03-01
Completion date
2025-06-30
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Responders

Brief summary

New Approach For Ovarian PRP Injection for poor responders

Detailed description

Poor ovarian responders are at high risk of unsuccessful IVF/ICSI trials. In the last few years, many studies showed significant improvement of ovarian reserve parameters after PRP injection. There was no consensus regarding the route of injection, the volume injected, the location of PRP injection inside the ovary, the number of injection and the number of the cycle in which PRP is injected.

Interventions

None listed

Sponsors

Bassem Ayman Mahmoud Assaf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* AMH : \< 0.5 ng/ml * FSH: \> 10 miu but \< 25 miu. * AFC : \< 5 in both ovaries * Poor ovarian response, in a previous IVF/ICSI trial , resulting in 3 or fewer oocytes. * Normal uterine cavity , demonstrated by a recent hysteroscopy

Exclusion criteria

* Primary ovarian insufficiency with FSH \> 25 miu. * Previous ovarian surgery or Chemotherapy. * On going Anticoagulant use. * Carcinomas or a history of chronic pelvic pain. * Present infection. * Hemoglobin level lower than 11 g/L * platelet count lower than 150 x 10³/μL.

Design outcomes

Primary

MeasureTime frameDescription
PRP effect on ovary for better fertility outcomeone yearThis is a prospective cohort clinical observational study. Aiming at evaluating the clinical effects of injecting PRP(Platelet Rich Plasma) into ovaries, of poor responders, taking all measures which may improve the response rate. That is why we will inject PRP for 2 consecutive cycles, the first cycle via laparoscopy and the next cycle, via ultrasonography.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026